Skip to main content
Article thumbnail
Location of Repository

A Review of Economic Evaluations of Tobacco Control Programs

By Jennifer W. Kahende, Brett R. Loomis, Bishwa Adhikari and LaTisha Marshall


Each year, an estimated 443,000 people die of smoking-related diseases in the United States. Cigarette smoking results in more than $193 billion in medical costs and productivity losses annually. In an effort to reduce this burden, many states, the federal government, and several national organizations fund tobacco control programs and policies. For this report we reviewed existing literature on economic evaluations of tobacco control interventions. We found that smoking cessation therapies, including nicotine replacement therapy (NRT) and self-help are most commonly studied. There are far fewer studies on other important interventions, such as price and tax increases, media campaigns, smoke free air laws and workplace smoking interventions, quitlines, youth access enforcement, school-based programs, and community-based programs. Although there are obvious gaps in the literature, the existing studies show in almost every case that tobacco control programs and policies are either cost-saving or highly cost-effective

Topics: Review
Publisher: Molecular Diversity Preservation International (MDPI)
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1984). A cost-benefit analysis of a smoking cessation program. Eval. program plan.
  2. (1994). A cost-benefit analysis of smoking cessation programs during the first trimester of pregnancy for the prevention of low birthweight.
  3. (1990). A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women.
  4. (1997). A mass media programme to prevent smoking among adolescents: costs and cost effectiveness.
  5. (1994). Analysis of taxable sales receipts: was New York City’s Smoke-Free Air Act bad for restaurant business?
  6. (1983). and cost outcomes of an HMO-based prenatal health education program. Public Health Rep.
  7. (2007). Campaign for Tobacco Free Kids. History on State Spending for Tobacco Prevention. Accessed
  8. (2003). Changes of attitudes and patronage behaviors in response to a smoke-free bar law.
  9. (2004). Changes of knowledge, attitudes, beliefs, and preference of bar owner and staff in response to a smoke-free bar law. Tob. Control
  10. (2005). Cigarette tax increase and media campaign. Cost of reducing smoking-related deaths.
  11. (1996). Cost effectiveness in health and medicine;
  12. (2005). Cost effectiveness of a community based research project to help women quit smoking.
  13. (1997). Cost effectiveness of a mass media-led anti-smoking campaign in Scotland. Tob. Control
  14. (2001). Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomized controlled trial. BMJ
  15. (1997). Cost effectiveness of smoking-cessation therapies. Pharmacoeconomics
  16. (1993). Cost of smoking to the Medicare program,
  17. (1998). Cost-effectiveness of a hospital-based smoking cessation intervention. Med. Care
  18. (2001). Cost-effectiveness of a schoolbased tobacco-use prevention program.
  19. (1993). Cost-effectiveness of a smoking cessation program after myocardial infarction.
  20. (1996). Cost-effectiveness of smoking cessation modalities: comparing apples with oranges?
  21. (1997). Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation.
  22. (1996). Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians’ smoking cessation counseling.
  23. (1997). Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience.
  24. (2000). Cost-utility analyses of clinical preventive services.
  25. (1998). Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics
  26. (1993). Discounting in the economic evaluation of health care interventions.
  27. (1999). Disease Control and Prevention (CDC). Best practices for comprehensive tobacco control programs.
  28. (1992). Disease Control and Prevention. Assessment of the impact of a 100% smoke-free ordinance on restaurant sales –
  29. (2002). Disease Control and Prevention. Impact of a smoking ban on restaurant and bar revenue – El Paso,
  30. (1993). Economic implications of smoking cessation therapies: a review of economic appraisals. Pharmacoeconomics
  31. (1991). Effect of cost on the selfadministration and efficacy of nicotine gum: a preliminary study.
  32. (2004). Efficacy and cost-effectiveness of a minimal intervention to prevent smoking relapse: dismantling the effects of amount of content versus content.
  33. (1992). Estimation of the breakeven point for smoking cessation programs in pregnancy.
  34. (2002). Foundation. Saving lives, saving money: why states should invest in a tobaccofree future. American Legacy Foundation:
  35. (2005). Free nicotine replacement therapy programs vs. implementing smokefree workplaces: a cost-effectiveness comparison.
  36. (2002). Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies. Nicotine Tob. Res.
  37. (2005). Increasing excise taxes on cigarettes in California: a dynamic simulation of health and economic impacts.
  38. (2003). Long term compliance with California’s smoke-free workplace law among bars and restaurants in Los Angeles County. Tob. Control
  39. Methods for the economic evaluation of health care programmes, 2 nd Ed.;
  40. (2002). Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice. Pharmacotherapy
  41. (2007). of Health and Aging. Returns on investment in public health: an epidemiological and economic analysis (2003). Accessed
  42. (2000). of Health and Human Services. Reducing tobacco use: a report of the Surgeon General.
  43. (2004). of Health and Human Services. The health consequences of smoking: a report of the Surgeon General.
  44. (1990). Pregnancy medical cost outcomes of a self-help prenatal smoking cessation program in an HMO. Public Health Rep.
  45. (1999). Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness.
  46. (2003). Prevention effectiveness: a guide to decision analysis and economic evaluation, 2 nd Ed.;
  47. (2004). Prevention of smoking-related deaths in the United States.
  48. (2006). Priorities among effective clinical preventive services: results of a systematic review and analysis.
  49. (2004). Quitline in smoking cessation: a cost-effectiveness analysis.
  50. (2003). Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry. Tob. Control
  51. (2001). Simulated effect of tobacco tax variation on population health in California.
  52. (2005). Smoke-free law did not affect revenue from gaming in Delaware.
  53. (2005). Smoke-free laws and bar revenues in California—the last call. Health Econ.
  54. (2001). Smoking cessation interventions and policies to promote their use: a critical review. Nicotine Tob. Res.
  55. (2000). Smoking-attributable mortality, years of potential life lost, and productivity losses—United States,
  56. (2005). State tobacco control spending and youth smoking.
  57. (2001). Sudden infant death syndrome, maternal smoking during pregnancy, and the costeffectiveness of smoking cessation intervention.
  58. (2005). Task Force on Community Preventive Services. The guide to community preventive services: what works to promote health?;
  59. (2004). Telephone assistance for smoking cessation: one year cost effectiveness estimations. Tob. Control
  60. (1996). The Agency for Health Care Policy and Research. Smoking Cessation Clinical Practice Guideline.
  61. (2008). The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.
  62. (2004). The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles. Tob. Control
  63. (1989). The cost-effectiveness of counseling smokers to quit.
  64. (2001). The cost-effectiveness of intensive national school-based anti-tobacco education: results from the tobacco policy model.
  65. (1997). The cost-effectiveness of the nicotine transdermal patch for smoking cessation.
  66. (1993). The costs and benefits of smoking restrictions: an assessment of the Smoke-Free Environment Act of
  67. (1990). The costs of smoking and the cost effectiveness of smoking-cessation programs.
  68. (1999). The economic effect of smoke-free restaurant policies on restaurant business in Masssachusetts.
  69. (1997). The effect of ordinances requiring smoke-free restaurants and bars on revenues: a follow-up.
  70. (1994). The effect of ordinances requiring smoke-free restaurants on restaurant sales.
  71. (2006). The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General.
  72. (1998). Use and cost effectiveness of smokingcessation services under four insurance plans in a health maintenance organization.
  73. (2001). What is the potential cost-effectiveness of enforcing a prohibition on the sale of tobacco to minors?

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.